🇺🇸 FDA
Pipeline program

LEN+SIN+DEB-TACE+HAIC

MIIR-25

Phase 2 other active

Quick answer

LEN+SIN+DEB-TACE+HAIC for Hepatocellular Carcinoma Non-resectable is a Phase 2 program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Hepatocellular Carcinoma Non-resectable
Phase
Phase 2
Modality
other
Status
active

Clinical trials